Ahmadi Ganjeh, Z., Eslami-Kalantari, M., and Mowlavi, A. A. (2019). Dosimetry calculations of involved and noninvolved organs in proton therapy of liver cancer: a simulation study. Nuclear Science and Techniques, 30:1–7.
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68(6):394–424.
Brenner, D. J., Elliston, C. D., Hall, E. J., et al. (2009). Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator. Physics in Medicine & Biology, 54(20):6065.
Brenner, D. J. and Hall, E. J. (2008). Secondary neutrons in clinical proton radiotherapy: a charged issue. Radiotherapy and Oncology, 86(2):165–170.
Chen, Y., Grassberger, C., Li, J., et al. (2018). Impact of potentially variable RBE in liver proton therapy. Physics in Medicine & Biology, 63(19):195001.
Chuong, M., Kaiser, A., Molitoris, J., et al. (2020). Proton beam therapy for liver cancers. Journal of Gastrointestinal Oncology, 11(1):157.
Dionisi, F., Brolese, A., Siniscalchi, B., et al. (2021). Clinical results of active scanning proton therapy for primary liver tumors. Tumori Journal, 107(1):71–79.
Doyen, J., Falk, A. T., Floquet, V., et al. (2016). Proton beams in cancer treatments: Clinical outcomes and dosimetric comparisons with photon therapy. Cancer Treatment Reviews, 43:104–112.
Gandhi, S. J., Liang, X., Ding, X., et al. (2015). Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: Photons versus protons. Practical Radiation Oncology, 5(4):209–218.
Hälg, R. A. and Schneider, U. (2020). Neutron dose and its measurement in proton therapy current state of knowledge. The British Journal of Radiology, 93(1107):20190412.
Hashemi, Z., Tatari, M., and Naik, H. (2020). Simulation of dose distribution and secondary particle production in proton therapy of brain tumor. Reports of Practical Oncology & Radiotherapy, 25(6):927–933.
Howell, R. (2012). Second primary cancers and cardiovascular disease after radiation therapy. NCRP report no. 170. Medical Physics, 39(12):7729–7731.
Jarlskog, C. Z., Lee, C., Bolch, W. E., et al. (2008). Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age dependent voxel phantoms. Physics in Medicine & Biology, 53(3):693.
Jia, S. B., Hadizadeh, M. H., Mowlavi, A. A., et al. (2014). Evaluation of energy deposition and secondary particle production in proton therapy of brain using a slab head phantom. Reports of Practical Oncology and Radiotherapy, 19(6):376– 384.
Jiang, H., Wang, B., Xu, X. G., et al. (2005). Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment. Physics in Medicine & Biology, 50(18):4337.
Keane, F. K., Wo, J. Y., Zhu, A. X., et al. (2016). Liver- directed radiotherapy for hepatocellular carcinoma. Liver Cancer, 5(3):198–209.
Kraft, G. (2000). Tumor therapy with heavy charged particles. Progress in particle and Nuclear Physics, 45:S473–S544.
Kry, S. F., Bednarz, B., Howell, R. M., et al. (2017). AAPM TG 158: measurement and calculation of doses outside the treated volume from external-beam radiation therapy. Medical Physics, 44(10):e391–e429.
Malmer, C. J. (2001). ICRU report 63. nuclear data for neutron and proton radiotherapy and for radiation protection. Medical Physics, 28(5):861.
Paganetti, H. (2002). Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles. Physics in Medicine & Biology, 47(5):747.
Polf, J., Peterson, S., McCleskey, M., et al. (2009). Measurement and calculation of characteristic prompt gamma ray spectra emitted during proton irradiation. Physics in Medicine & Biology, 54(22):N519.
Snyder, W. S., Ford, M. R., Warner, G. G., et al. (1969). Esti- mates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. Technical report, Oak Ridge National Lab., Tenn.
Taddei, P. J., Mirkovic, D., Fontenot, J. D., et al. (2009). Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams. Physics in Medicine & Biology, 54(8):2259.
Wang, X., Krishnan, S., Zhang, X., et al. (2008). Proton radiotherapy for liver tumors: dosimetric advantages over photon plans. Medical Dosimetry, 33(4):259–267.
Xu, X. G., Bednarz, B., and Paganetti, H. (2008). A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction. Physics in Medicine & Biology, 53(13):R193.
Zheng, Y., Liu, Y., Zeidan, O., et al. (2012). Measurements of neutron dose equivalent for a proton therapy center using uniform scanning proton beams. Medical Physics, 39(6Part1):3484–3492.